Department of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA; Huffington Center on Aging, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Cell Metab. 2019 Jun 4;29(6):1274-1290.e9. doi: 10.1016/j.cmet.2019.03.001. Epub 2019 Mar 28.
Telomere shortening is associated with stem cell decline, fibrotic disorders, and premature aging through mechanisms that are incompletely understood. Here, we show that telomere shortening in livers of telomerase knockout mice leads to a p53-dependent repression of all seven sirtuins. P53 regulates non-mitochondrial sirtuins (Sirt1, 2, 6, and 7) post-transcriptionally through microRNAs (miR-34a, 26a, and 145), while the mitochondrial sirtuins (Sirt3, 4, and 5) are regulated in a peroxisome proliferator-activated receptor gamma co-activator 1 alpha-/beta-dependent manner at the transcriptional level. Administration of the NAD(+) precursor nicotinamide mononucleotide maintains telomere length, dampens the DNA damage response and p53, improves mitochondrial function, and, functionally, rescues liver fibrosis in a partially Sirt1-dependent manner. These studies establish sirtuins as downstream targets of dysfunctional telomeres and suggest that increasing Sirt1 activity alone or in combination with other sirtuins stabilizes telomeres and mitigates telomere-dependent disorders.
端粒缩短与干细胞减少、纤维化疾病和早衰有关,但其中的机制尚未完全阐明。在这里,我们发现端粒酶敲除小鼠肝脏中的端粒缩短会导致 p53 依赖性抑制所有七种 Sirtuins。p53 通过 microRNAs(miR-34a、26a 和 145)对非线粒体 Sirtuins(Sirt1、2、6 和 7)进行转录后调控,而线粒体 Sirtuins(Sirt3、4 和 5)则通过过氧化物酶体增殖物激活受体 γ 共激活因子 1α/β 在转录水平上进行调节。NAD(+)前体烟酰胺单核苷酸的给药维持端粒长度,抑制 DNA 损伤反应和 p53,改善线粒体功能,并以部分依赖 Sirt1 的方式在功能上挽救肝纤维化。这些研究将 Sirtuins 确立为功能失调端粒的下游靶点,并表明单独增加 Sirt1 活性或与其他 Sirtuins 联合使用可稳定端粒并减轻端粒依赖性疾病。